Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12234460
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted -
US 12233051
Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase
granted -
US 12227508
TGF-β inhibitors
granted -
US 12226425
Inhibitors of ARG1 and/or ARG2
granted -
US 12221491
PSMD9 inhibitors for the treatment of hepatic lipid dysregulation
granted -
US 12220415
WEE1 kinase inhibitors and methods of treating cancer using the same
granted -
US 12220421
Inhibitors of C. difficile spore germination
granted -
US 12221441
Plasma kallikrein inhibitors and uses thereof
granted -
US 12219327
Substituted isoindolines as PI3K-alpha inhibitors
granted -
US 12215322
Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors
granted -
US 12213973
Bacterial nitric oxide synthase inhibitors
granted -
US 12209085
RET inhibitors, pharmaceutical compositions and uses thereof
granted -
US 12209116
Recombinant human C1 esterase inhibitor and uses thereof
granted -
US 12209073
Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor
granted -
US 12202845
Ras inhibitors
granted -
US 12201617
HDAC6 inhibitors for treatment of metabolic disease and HFpEF
granted -
US 12186313
Pyridazinone compounds and their use as DAAO inhibitors
granted -
US 12187746
C26-linked rapamycin analogs as mTOR inhibitors
granted -
US 12187754
LpxC inhibitors and uses thereof
granted -
US 12186324
Imidazopiperazine inhibitors of transcription activating proteins
granted -
US 12187792
IL-4/IL-13 pathway inhibitors for enhanced efficacy in treating cancer
granted -
US 12187694
SLC26A3 inhibitors and use thereof
granted -
US 12187731
Compounds useful as inhibitors of ATR kinase
granted -
US 12172994
Pyrimidine compound as JAK kinase inhibitor
granted